The Immune System and its Frontier Defense Against Herpes
Herpes Simple Virus Type II is capable of eluding vaccines that utilize the body’s adaptive immune response. Yale Professor of Immunobiology Akiko Iwasaki and her research group have discovered a network of immune cells that provides sustained protection at the site of infection, suggesting a more effective approach to vaccine development.